Redox-responsive micellar nanoparticles from glycosaminoglycans for CD44 targeted drug delivery

dc.commentshttp://3bs.uminho.pt/node/19527por
dc.contributor.authorCarvalho, A. M.por
dc.contributor.authorTeixeira, R.por
dc.contributor.authorNovoa-Carballal, R.por
dc.contributor.authorPires, R. A.por
dc.contributor.authorReis, R. L.por
dc.contributor.authorPashkuleva, I.por
dc.date.accessioned2018-10-17T16:33:50Z
dc.date.available2020-06-01T06:00:17Z
dc.date.issued2018-05
dc.date.submitted2018-05
dc.date.updated2018-10-17T15:08:06Z
dc.description.abstractCancer progression is associated with overexpression of various receptors at the cell surface. Among these, CD44 is known to recognize and bind specifically hyaluronan (HA) and interact with less affinity to other glycosaminoglycans (GAGs), such as chondroitin sulfate (CS). In this study, we describe a simple method to obtain micellar nanoparticles with a GAG shell (HA or CS) as potential drug delivery systems that target cancer cells overexpressing CD44. Alkanethiol was conjugated at the reducing end of the respective GAG using highly efficient oxime chemistry. The alkane moiety confers amphiphilic behavior to the obtained conjugates and triggers their self-assembly into micellar nanoparticles, while the thiol group adds redox-responsiveness to the system. The properties of the particles depend on the used GAG: HA amphiphiles form more dense, smaller assemblies that are redox sensitive. Both systems allow encapsulation of either hydrophobic or hydrophilic cargos with high efficiency. We demonstrate that the GAGs exposed on the surface of the nanoparticles are with preserved bioactivity and recognized by the cellular receptors: the particles were internalized via CD44 dependent pathways.por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.description.sponsorshipThe authors thank the Portuguese FCT (Grants no: SFRH/BD/114847/2016, IF/00032/2013 and IF/00373/2014) and EC (ComplexiTE ERC-2012-ADG 20120216-321266, H2020-TWIN CHEM2NATURE-692333, H2020-WIDESPREAD-FoReCaST-668983 and EuroNanoMed CytoNanoHeal) for providing financial support to this project.por
dc.distributioninternationalpor
dc.identifier.citationCarvalho A. M., Teixeira R., Novoa-Carballal R., Pires R. A., Reis R. L., Pashkuleva I. Redox-responsive micellar nanoparticles from glycosaminoglycans for CD44 targeted drug delivery, Biomacromolecules, Vol. 19, Issue 7, pp. 2991 - 2999, doi:10.1021/acs.biomac.8b00561, 2018por
dc.identifier.doi10.1021/acs.biomac.8b00561por
dc.identifier.issn1526-4602por
dc.identifier.pmid29758159por
dc.identifier.urihttps://hdl.handle.net/1822/56284
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherACSpor
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F114847%2F2016/PTpor
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/321266/EUpor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/692333/EUpor
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/668983/EUpor
dc.relationinfo:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F00032%2F2013%2FCP1158%2FCT0009/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/Investigador FCT/IF%2F00373%2F2014%2FCP1212%2FCT0013/PT
dc.relation.publisherversionhttps://pubs.acs.org/doi/pdf/10.1021/acs.biomac.8b00561por
dc.rightsopenAccesspor
dc.subjectCD44por
dc.subjectchondroitin sulfatepor
dc.subjectHyaluronic acidpor
dc.subjectmicellar nanoparticlespor
dc.subjectself-assemblypor
dc.subject.wosScience & Technologypor
dc.titleRedox-responsive micellar nanoparticles from glycosaminoglycans for CD44 targeted drug deliverypor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationEndPage2999por
oaire.citationIssue7por
oaire.citationStartPage2991por
oaire.citationVolume19por
sdum.journalBiomacromoleculespor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
19527-Carvalho et al_Biomacromol_2018.pdf
Tamanho:
2.48 MB
Formato:
Adobe Portable Document Format